An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

Conditions: Evaluate Ketogenic Stress
Interventions: Drug: Exenatide/Exenatide extended release; Drug: Dapagliflozin; Drug: Placebo
Sponsors: University at Buffalo; AstraZeneca
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 1, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments